Skip to content
lifestyle.wordsjournal.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Alvotech
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
August 21, 2026
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
August 19, 2026
Alvotech to Report Financial Results for H1 2026
August 10, 2026
Alvotech announces successful closure of FDA inspection of manufacturing facility
July 29, 2026
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
May 11, 2026
Alvotech Q1 2026 Financial Results
May 6, 2026
Alvotech Announces a Change in its Executive Team
April 30, 2026
Alvotech to Report Financial Results for the First Quarter of 2026
April 24, 2026
Alvotech Files Annual Report with the SEC
March 30, 2026
Alvotech Q4 2025 and Full Year 2025 Financial Results
March 18, 2026
1
2
Next Page
→